Cargando…
1198. Lyme Disease Post-Exposure Prophylaxis by Single-Dose Doxycycline in Three Healthcare Systems
BACKGROUND: Lyme disease, the most common tickborne disease in the United States, may be prevented by taking a single 200-mg dose of oral doxycycline after a high-risk bite from a blacklegged tick. Currently, it is not known how Lyme disease post-exposure prophylaxis (PEP) might vary by region and h...
Autores principales: | Marx, Grace E, Schotthoefer, Anna M, Schwartz, Brian S, Draper, Evan, Rivera, Christina G, Zeuli, John, Scotty, Erica, Pollak, Jonathan S, Schwartz, Amy M, Beck, Alyssa, Hinckley, Alison F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643734/ http://dx.doi.org/10.1093/ofid/ofab466.1390 |
Ejemplares similares
-
1614. Single-Dose Doxycycline as Lyme Disease Post-Exposure Prophylaxis in a National Commercial Insurance Claims Database―the United States, 2014–2017
por: Marx, Grace E, et al.
Publicado: (2019) -
153. Utilization of Post-Exposure Prophylaxis to Prevent Lyme Disease in a Large US Healthcare Database
por: Marx, Grace E, et al.
Publicado: (2021) -
1428. Lyme Disease Treatment in the United States: Prescribing Patterns from a Nationwide Commercial Insurance Database, 2016-2018
por: Beeson, Amy M, et al.
Publicado: (2020) -
Use of Commercial Claims Data for Evaluating Trends in Lyme Disease Diagnoses, United States, 2010–2018
por: Schwartz, Amy M., et al.
Publicado: (2021) -
Post-treatment Lyme borreliosis in context: Advancing the science and patient care
por: Marx, Grace E., et al.
Publicado: (2021)